Pharmaceutical composition for treating cancer
The present invention relates to an antigen composition comprising at least one mesothelioma cell associated antigen and a pharmaceutically acceptable carrier for use in the treatment of cancer, in particular mesothelioma, wherein the antigen composition is loaded to dendritic cells and wherein the...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to an antigen composition comprising at least one mesothelioma cell associated antigen and a pharmaceutically acceptable carrier for use in the treatment of cancer, in particular mesothelioma, wherein the antigen composition is loaded to dendritic cells and wherein the loaded dendritic cells are administered to a patient in combination with one or more checkpoint inhibitors. The invention also relates to an antigen composition comprising at least two mesothelioma cell associated antigens and a pharmaceutically acceptable carrier. The invention also relates to an antigen composition comprising at least two mesothelioma cell associated antigens and a pharmaceutically acceptable carrier for use as a medicament, in particular for the treatment of mesothelioma.
本发明涉及用于治疗癌症、特别是间皮瘤的包含至少一种间皮瘤癌细胞相关抗原和药学上可接受的载体的抗原组合物,其中所述抗原组合物负载至树突细胞并且其中将所述负载的树突细胞与一种或多种检查点抑制剂组合施用给患者。本发明还涉及包含至少两种间皮瘤癌细胞相关抗原和药学上可接受的载体的抗原组合物。本发明还涉及用作药物、特别是用于治疗间皮瘤的包含至少两种间皮瘤癌细胞相关抗原和药学上可接受的载体的抗原组合物。 |
---|